Company / Working Capital per Share
AVADEL PHARMACEUTICALS PLC Working Capital per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$0.90
FY2024
5-year range
$0.75 / $4.52
FY2020-FY2024
Trend
-26.1%
vs FY2023
Sector context
#184 of 210
Health Care
What the data says
AVADEL PHARMACEUTICALS PLC's working capital per share of $0.90 is lower than 88% of companies in the Health Care sector (FY2024). Working Capital per Share has fluctuated over the past 10 years, ranging from $0.75 in FY2022 to $4.52 in FY2020.
Based on SEC 10-K filings.
0.90 in FY2024 with a 5-year CAGR of -6.3%.
Improved from $0.75 to $0.90 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -32.6%
- 5-Year CAGR
- -6.3%
- 10-Year CAGR
- -
Sector benchmark
-99.4% below sector average
Key checks
Key Insights
- In FY2024, working capital per share decreased 26.1% year-over-year.
- Ranks #184 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2020.
- Lowest working capital per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -28.9%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.90 | -26.1% |
| FY2023 | $1.21 | +62.0% |
| FY2022 | $0.75 | -74.4% |
| FY2021 | $2.93 | -35.2% |
| FY2020 | $4.52 | +264.4% |
| FY2019 | $1.24 | -46.5% |
| FY2018 | $2.32 | +158.5% |
| FY2017 | $0.90 | -68.9% |
| FY2016 | $2.88 | +3.7% |
| FY2015 | $2.78 | +142.5% |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026